OMCL

Omnicell, Inc.

$35.90

-3.88%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process.

Source: Yahoo Finance
AI summary

Price & performance

1M+9.8%
3M+2.3%
YTD-15.8%
1Y+6.4%
52-week range—
Beta0.83
Full chart and returns against a benchmark

Q-Score

64/ 100

Quality against peers; 50 is the peer median.

Growth49
Risk64
Performance48
Valuation73
Profitability61
Leverage73
Sentiment69
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.2B+6.5%
Net income$2.1M-83.6%
Net margin0.2%-1.0 pts
Historical fundamentals

Revenue exposure

10%of revenue from outside the US
United States90%
Non-US10%
Regions, segments, customers and suppliers

Valuation

OMCLIndustryP/E36.9767.40P/S1.334.25EV/EBITDA9.3644.97P/B1.256.14PEG0.300.25
Dividend yield0.00%
Every valuation metric

Earnings

Oct 29next report, before the open
EPS estimate$0.42
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate